Inventor · disambiguated record
Marshall L. Grant
Also filed as: GRANT MARSHALL · GRANT MARSHALL L
33 granted patents·19 pending applications·336 citations·filing 2005–2025
97Inventor score
Top patents by PatentIndex Score
52 records- 0198US8778403B2Diketopiperazine microparticles with defined specific surface areasMANNKIND CORP·Filed 2013·Granted Jul 15, 2014·48 cites·20 claims
- 0298US8039431B2Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agentMANNKIND CORP·Filed 2007·Granted Oct 18, 2011·58 cites·16 claims
- 0396US8551528B2Diketopiperazine microparticles with defined specific surface areasGRANT MARSHALL L·Filed 2010·Granted Oct 8, 2013·53 cites·19 claims
- 0495US8512932B2Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agentWILSON BRYAN R·Filed 2011·Granted Aug 20, 2013·54 cites·27 claims
- 0593US11013691B2Heat-stable dry powder pharmaceutical compositions and methodsMANNKIND CORP·Filed 2019·Granted May 25, 2021·6 cites·11 claims
- 0692US10772883B2Diketopiperazine microparticles with defined specific surface areasMANNKIND CORP·Filed 2017·Granted Sep 15, 2020·6 cites·12 claims
- 0791US8785396B2Method and composition for treating migrainesLEONE-BAY ANDREA·Filed 2011·Granted Jul 22, 2014·17 cites·13 claims
- 0891US8642548B2Val (8) GLP-1 composition and method for treating functional dyspepsia and/or irritable bowel syndromeRICHARDSON PETER·Filed 2010·Granted Feb 4, 2014·41 cites·19 claims
- 0989US9925144B2Heat-stable dry powder pharmaceutical compositions and methodsMANNKIND CORP·Filed 2014·Granted Mar 27, 2018·13 cites·24 claims
- 1089US8734845B2Diketopiperazine microparticles with defined specific surface areasGRANT MARSHALL L·Filed 2010·Granted May 27, 2014·9 cites·20 claims
- 1187US12383552B2Diketopiperazine microparticles with defined specific surface areasMANNKIND CORP·Filed 2023·Granted Aug 12, 2025·0 cites·13 claims
- 1287US10413513B2Heat-stable dry powder pharmaceutical compositions and methodsMANNKIND CORP·Filed 2018·Granted Sep 17, 2019·5 cites·23 claims
- 1387US2023414500A1Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agentMANNKIND CORP·Filed 2023·Application pending·0 cites
- 1485US9630930B2Diketopiperazine microparticles with defined specific surface areasMANNKIND CORP·Filed 2014·Granted Apr 25, 2017·4 cites·21 claims
- 1583US9364436B2High capacity diketopiperazine microparticles and methodsGRANT MARSHALL·Filed 2012·Granted Jun 14, 2016·6 cites·21 claims
- 1682US9283193B2Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agentsMANNKIND CORP·Filed 2014·Granted Mar 15, 2016·2 cites·10 claims
- 1781US11013692B2Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agentsMANNKIND CORP·Filed 2019·Granted May 25, 2021·0 cites·19 claims
- 1881US10421729B2Microcrystalline diketopiperazine compositions and methodsMANNKIND CORP·Filed 2014·Granted Sep 24, 2019·3 cites·21 claims
- 1981US10357459B2Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agentsMANNKIND CORP·Filed 2017·Granted Jul 23, 2019·1 cites·15 claims
- 2081US2023016875A1High capacity diketopiperazine microparticles and methodsMANNKIND CORP·Filed 2022·Application pending·0 cites
- 2180US11110151B2Composition and method for reducing hypoglycemia events in diabetes treatmentMANNKIND CORP·Filed 2019·Granted Sep 7, 2021·1 cites·12 claims
- 2280US10159644B2Inhalable vaccine compositions and methodsMANNKIND CORP·Filed 2013·Granted Dec 25, 2018·5 cites·20 claims
- 2379US9241903B2Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agentMANNKIND CORP·Filed 2013·Granted Jan 26, 2016·2 cites·24 claims
- 2478US2025154113A1Microcrystalline Diketopiperazine Compositions and MethodsMANNKIND CORP·Filed 2025·Application pending·0 cites
- 2577US10130709B2High capacity diketopiperazine microparticles and methodsMANNKIND CORP·Filed 2016·Granted Nov 20, 2018·1 cites·9 claims
- 2676US11607410B2Diketopiperazine microparticles with defined specific surface areasMANNKIND CORP·Filed 2020·Granted Mar 21, 2023·0 cites·10 claims
- 2776US10130581B2Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agentMANNKIND CORP·Filed 2015·Granted Nov 20, 2018·1 cites·14 claims
- 2876US2025152579A1Diketopiperazine Microparticles with Defined Specific Surface AreasMANNKIND CORP·Filed 2025·Application pending·0 cites
- 2976US2024342251A1Method of treating hypoglycemia events in diabetes treatmentMANNKIND CORP·Filed 2024·Application pending·0 cites
- 3075US2022048868A1Microcrystalline Diketopiperazine Compositions and MethodsMANNKIND CORP·Filed 2021·Application pending·0 cites
- 3173US2024390274A1Method and composition for treating obesityMANNKIND CORP·Filed 2024·Application pending·0 cites
- 3273US2024180897A1Methods and compositions for treating pulmonary hypertensionMANNKIND CORP·Filed 2024·Application pending·0 cites
- 3371US11980656B2Method of treating hypoglycemia events in diabetes treatmentMANNKIND CORP·Filed 2021·Granted May 14, 2024·0 cites·6 claims
- 3471US11192862B2Microcrystalline diketopiperazine compositions and methodsMANNKIND CORP·Filed 2020·Granted Dec 7, 2021·0 cites·9 claims
- 3571US10603383B2High capacity diketopiperazine microparticles and methodsMANNKIND CORP·Filed 2019·Granted Mar 31, 2020·0 cites·12 claims
- 3670US11433135B2High capacity diketopiperazine microparticles and methodsMANNKIND CORP·Filed 2020·Granted Sep 6, 2022·0 cites·16 claims
- 3770US2021244667A1Heat-stable dry powder pharmaceutical compositions and methodsMANNKIND CORP·Filed 2021·Application pending·0 cites
- 3869US10745359B2Microcrystalline diketopiperazine compositions and methodsMANNKIND CORP·Filed 2019·Granted Aug 18, 2020·0 cites·11 claims
- 3969US10376466B2Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agentMANNKIND CORP·Filed 2018·Granted Aug 13, 2019·0 cites·6 claims
- 4069US2019314276A1Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agentMANNKIND CORP·Filed 2019·Application pending·0 cites
- 4169US2023130606A1Methods and compositions for treating pulmonary hypertensionMANNKIND CORP·Filed 2022·Application pending·0 cites
- 4268US10376587B2High capacity diketopiperazine microparticles and methodsMANNKIND CORP·Filed 2018·Granted Aug 13, 2019·0 cites·14 claims
- 4366US12370137B2Method and composition for treating obesityMANNKIND CORP·Filed 2019·Granted Jul 29, 2025·0 cites·12 claims
- 4466US9717689B2Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agentsMANNKIND CORP·Filed 2016·Granted Aug 1, 2017·0 cites·20 claims
- 4566US2020405731A1Method and composition for administering prostaglandinsMANNKIND CORP·Filed 2020·Application pending·0 cites
- 4664US2025312419A1Pharmaceutical compositions and methodsMANNKIND CORP·Filed 2023·Application pending·0 cites
- 4760US2014315953A1Method and composition for treating migrainesMANNKIND CORP·Filed 2014·Application pending·0 cites
- 4859US2025288515A1Method and composition for treating lung diseasesMANNKIND CORP·Filed 2023·Application pending·0 cites
- 4955US2017232001A1Method and composition for treating migrainesMANNKIND CORP·Filed 2017·Application pending·0 cites
- 5047US2014187490A1Val (8) GLP-1 Composition and Method for Treating Functional Dyspepsia and/or Irritable Bowel SyndromeROSE PHARMA AS·Filed 2013·Application pending·0 cites
Showing the top 50 of 52 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →